July 6, 2022

Omnichannel diagnostics platform Redcliffe Lifetech on Friday introduced it has raised $61 million led by LeapFrog Investments, and can broaden its attain into tier 2, 3 and 4 cities throughout the nation.

The brand new funds may also be utilised to scale its platform and enhance its product choices to radiology, illness information profiling and life-style administration, the corporate stated in a press release.

“Preventative drugs is the way forward for well being in India. This funding will assist us scale quickly to realize our aim to achieve 500 million Indians inside the subsequent 5 years,” stated Dheeraj Jain, Founding father of Redcliffe Lifetech.

The newest funding spherical noticed participation from Healthquad, Schroders, LC Nueva, Progress Spark Ventures and present buyers Chiratae Ventures and Alkemi Enterprise Companions.

“Redcliffe is an exemplar of LeapFrog’s give attention to digital-led and asset-light enterprise fashions that allow entry to important healthcare providers to rising customers,” stated Biju Mohandas, Associate and International Co-Chief for Well being Investments at LeapFrog Investments.

Redcliffe delivers diagnostics providers in its community of22 labs throughout 14 cities, a number of of that are already NABL accredited.

Its omni-channel infrastructure combines modern on-line channels with a fleet of 400 phlebotomists working in additional than 100 cities with dwelling pattern assortment and an off-line community of 500 assortment centres.

(With inputs from IANS)

(To obtain our E-paper on whatsapp each day, please click on right here. We allow sharing of the paper’s PDF on WhatsApp and different social media platforms.)

Revealed on: Friday, Might 06, 2022, 10:14 AM IST

See also  Madhya Pradesh: Miscreants in Gwalior rob Rs 1 crore in broad daylight